跳到正文
原文
NIH· @NIH · X·· 28 天前AI 评分22
AI 导读

NIH资助的研究人员发现,将工程化转移RNA与一种已获批的囊性纤维化疗法联合使用,可改善该疾病相关蛋白的功能。 在应用于人类之前还需更多研究,但这些发现可能为因某些突变而对现有疗法无应答的患者带来希望。 了解更多:https://bit.ly/4zJYwhG

正文

NIH-funded researchers found that combining engineered transfer RNA with an approved cystic fibrosis treatment could improve function of the proteins affected by the disease.

More research is needed before it can be used in humans, but the findings may offer hope for people who don’t respond to current treatments due to certain mutations.

Learn more: https://bit.ly/4zJYwhG

来源:NIH · x.com